Cargando…
Parasympathetic autonomic dysfunction is more often evidenced than sympathetic autonomic dysfunction in fluctuating and polymorphic symptoms of "long-COVID" patients
Several disabling symptoms potentially related to dysautonomia have been reported in “long-COVID” patients. Unfortunately, these symptoms are often nonspecific, and autonomic nervous system explorations are rarely performed in these patients. This study aimed to evaluate prospectively a cohort of lo...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201474/ https://www.ncbi.nlm.nih.gov/pubmed/37217645 http://dx.doi.org/10.1038/s41598-023-35086-8 |
_version_ | 1785045270381199360 |
---|---|
author | Zanin, Adrien Amah, Guy Chakroun, Sahar Testard, Pauline Faucher, Alice Le, Thi Yen Vy Slama, Dorsaf Le Baut, Valérie Lozeron, Pierre Salmon, Dominique Kubis, Nathalie |
author_facet | Zanin, Adrien Amah, Guy Chakroun, Sahar Testard, Pauline Faucher, Alice Le, Thi Yen Vy Slama, Dorsaf Le Baut, Valérie Lozeron, Pierre Salmon, Dominique Kubis, Nathalie |
author_sort | Zanin, Adrien |
collection | PubMed |
description | Several disabling symptoms potentially related to dysautonomia have been reported in “long-COVID” patients. Unfortunately, these symptoms are often nonspecific, and autonomic nervous system explorations are rarely performed in these patients. This study aimed to evaluate prospectively a cohort of long-COVID patients presenting severe disabling and non-relapsing symptoms of potential dysautonomia and to identify sensitive tests. Autonomic function was assessed by clinical examination, the Schirmer test; sudomotor evaluation, orthostatic blood pressure (BP) variation, 24-h ambulatory BP monitoring for sympathetic evaluation, and heart rate variation during orthostatism, deep breathing and Valsalva maneuvers for parasympathetic evaluation. Test results were considered abnormal if they reached the lower thresholds defined in publications and in our department. We also compared mean values for autonomic function tests between patients and age-matched controls. Sixteen patients (median age 37 years [31–43 years], 15 women) were included in this study and referred 14.5 months (median) [12.0–16.5 months] after initial infection. Nine had at least one positive SARS-CoV-2 RT-PCR or serology result. Symptoms after SARS-CoV-2 infection were severe, fluctuating and disabling with effort intolerance. Six patients (37.5%) had one or several abnormal test results, affecting the parasympathetic cardiac function in five of them (31%). Mean Valsalva score was significantly lower in patients than in controls. In this cohort of severely disabled long-COVID patients, 37.5% of them had at least one abnormal test result showing a possible contribution of dysautonomia to these nonspecific symptoms. Interestingly, mean values of the Valsalva test were significantly lower in patients than in control subjects, suggesting that normal values thresholds might not be appropriate in this population. |
format | Online Article Text |
id | pubmed-10201474 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-102014742023-05-23 Parasympathetic autonomic dysfunction is more often evidenced than sympathetic autonomic dysfunction in fluctuating and polymorphic symptoms of "long-COVID" patients Zanin, Adrien Amah, Guy Chakroun, Sahar Testard, Pauline Faucher, Alice Le, Thi Yen Vy Slama, Dorsaf Le Baut, Valérie Lozeron, Pierre Salmon, Dominique Kubis, Nathalie Sci Rep Article Several disabling symptoms potentially related to dysautonomia have been reported in “long-COVID” patients. Unfortunately, these symptoms are often nonspecific, and autonomic nervous system explorations are rarely performed in these patients. This study aimed to evaluate prospectively a cohort of long-COVID patients presenting severe disabling and non-relapsing symptoms of potential dysautonomia and to identify sensitive tests. Autonomic function was assessed by clinical examination, the Schirmer test; sudomotor evaluation, orthostatic blood pressure (BP) variation, 24-h ambulatory BP monitoring for sympathetic evaluation, and heart rate variation during orthostatism, deep breathing and Valsalva maneuvers for parasympathetic evaluation. Test results were considered abnormal if they reached the lower thresholds defined in publications and in our department. We also compared mean values for autonomic function tests between patients and age-matched controls. Sixteen patients (median age 37 years [31–43 years], 15 women) were included in this study and referred 14.5 months (median) [12.0–16.5 months] after initial infection. Nine had at least one positive SARS-CoV-2 RT-PCR or serology result. Symptoms after SARS-CoV-2 infection were severe, fluctuating and disabling with effort intolerance. Six patients (37.5%) had one or several abnormal test results, affecting the parasympathetic cardiac function in five of them (31%). Mean Valsalva score was significantly lower in patients than in controls. In this cohort of severely disabled long-COVID patients, 37.5% of them had at least one abnormal test result showing a possible contribution of dysautonomia to these nonspecific symptoms. Interestingly, mean values of the Valsalva test were significantly lower in patients than in control subjects, suggesting that normal values thresholds might not be appropriate in this population. Nature Publishing Group UK 2023-05-22 /pmc/articles/PMC10201474/ /pubmed/37217645 http://dx.doi.org/10.1038/s41598-023-35086-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Zanin, Adrien Amah, Guy Chakroun, Sahar Testard, Pauline Faucher, Alice Le, Thi Yen Vy Slama, Dorsaf Le Baut, Valérie Lozeron, Pierre Salmon, Dominique Kubis, Nathalie Parasympathetic autonomic dysfunction is more often evidenced than sympathetic autonomic dysfunction in fluctuating and polymorphic symptoms of "long-COVID" patients |
title | Parasympathetic autonomic dysfunction is more often evidenced than sympathetic autonomic dysfunction in fluctuating and polymorphic symptoms of "long-COVID" patients |
title_full | Parasympathetic autonomic dysfunction is more often evidenced than sympathetic autonomic dysfunction in fluctuating and polymorphic symptoms of "long-COVID" patients |
title_fullStr | Parasympathetic autonomic dysfunction is more often evidenced than sympathetic autonomic dysfunction in fluctuating and polymorphic symptoms of "long-COVID" patients |
title_full_unstemmed | Parasympathetic autonomic dysfunction is more often evidenced than sympathetic autonomic dysfunction in fluctuating and polymorphic symptoms of "long-COVID" patients |
title_short | Parasympathetic autonomic dysfunction is more often evidenced than sympathetic autonomic dysfunction in fluctuating and polymorphic symptoms of "long-COVID" patients |
title_sort | parasympathetic autonomic dysfunction is more often evidenced than sympathetic autonomic dysfunction in fluctuating and polymorphic symptoms of "long-covid" patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201474/ https://www.ncbi.nlm.nih.gov/pubmed/37217645 http://dx.doi.org/10.1038/s41598-023-35086-8 |
work_keys_str_mv | AT zaninadrien parasympatheticautonomicdysfunctionismoreoftenevidencedthansympatheticautonomicdysfunctioninfluctuatingandpolymorphicsymptomsoflongcovidpatients AT amahguy parasympatheticautonomicdysfunctionismoreoftenevidencedthansympatheticautonomicdysfunctioninfluctuatingandpolymorphicsymptomsoflongcovidpatients AT chakrounsahar parasympatheticautonomicdysfunctionismoreoftenevidencedthansympatheticautonomicdysfunctioninfluctuatingandpolymorphicsymptomsoflongcovidpatients AT testardpauline parasympatheticautonomicdysfunctionismoreoftenevidencedthansympatheticautonomicdysfunctioninfluctuatingandpolymorphicsymptomsoflongcovidpatients AT faucheralice parasympatheticautonomicdysfunctionismoreoftenevidencedthansympatheticautonomicdysfunctioninfluctuatingandpolymorphicsymptomsoflongcovidpatients AT lethiyenvy parasympatheticautonomicdysfunctionismoreoftenevidencedthansympatheticautonomicdysfunctioninfluctuatingandpolymorphicsymptomsoflongcovidpatients AT slamadorsaf parasympatheticautonomicdysfunctionismoreoftenevidencedthansympatheticautonomicdysfunctioninfluctuatingandpolymorphicsymptomsoflongcovidpatients AT lebautvalerie parasympatheticautonomicdysfunctionismoreoftenevidencedthansympatheticautonomicdysfunctioninfluctuatingandpolymorphicsymptomsoflongcovidpatients AT lozeronpierre parasympatheticautonomicdysfunctionismoreoftenevidencedthansympatheticautonomicdysfunctioninfluctuatingandpolymorphicsymptomsoflongcovidpatients AT salmondominique parasympatheticautonomicdysfunctionismoreoftenevidencedthansympatheticautonomicdysfunctioninfluctuatingandpolymorphicsymptomsoflongcovidpatients AT kubisnathalie parasympatheticautonomicdysfunctionismoreoftenevidencedthansympatheticautonomicdysfunctioninfluctuatingandpolymorphicsymptomsoflongcovidpatients |